Hedge Fund - Samsara BioCapital
Chinook Therapeutics Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q3 (2023-09-30) | $0 | 0% | 0 | $ |
| 2 | 2023 - Q2 (2023-06-30) | $198,319,737 | 34.8% | 5,161,888 | $ |
| 3 | 2023 - Q1 (2023-03-31) | $119,497,707 | 24.69% | 5,161,888 | $ |
| 4 | 2022 - Q4 (2022-12-31) | $135,241,466 | 29.1% | 5,161,888 | $ |
| 5 | 2022 - Q3 (2022-09-30) | $101,483,000 | 23.66% | 5,161,888 | $ |
| 6 | 2022 - Q2 (2022-06-30) | $90,281,000 | 24.06% | 5,161,888 | $ |
| 7 | 2022 - Q1 (2022-03-31) | $75,123,000 | 18.91% | 4,591,888 | $ |
| 8 | 2021 - Q4 (2021-12-31) | $74,894,000 | 14.52% | 4,591,888 | $ |
| 9 | 2021 - Q3 (2021-09-30) | $43,089,000 | 6.76% | 3,376,888 | $ |
| 10 | 2021 - Q2 (2021-06-30) | $44,738,000 | 5.52% | 3,168,388 | $ |
| 11 | 2021 - Q1 (2021-03-31) | $49,237,000 | 9.08% | 3,168,388 | $ |
| 12 | 2020 - Q4 (2020-12-31) | $50,251,000 | 5.05% | 3,168,388 | $ |
The displayed share prices are average quarterly stock market prices.